At meeting held on 08 February 2022
The Board of Suven Pharmaceuticals at its meeting held on 08 February 2022 has given its in-principle approval to evaluate the acquisition opportunity of Casper Pharma, an SEZ unit in Hyderabad engaged in Formulations. The Company will evaluate the proposal subject to financial, tax and legal due diligence to finalize the definitive agreementsPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
